Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
Racura Oncology has dosed the first patient in the HARNESS-1 Phase 1a/b…
June 25, 2026
AMTD Announces Positive Revenue Alert in 1H 2026, attributable to increased contributions from the Hospitality Arm through Successful Acquisitions of 4 Hotels
PARIS, NEW YORK, and LONDON, June 25, 2026 /PRNewswire/ — AMTD Group…
June 25, 2026
Bybit CEO Ben Zhou: The Future of Exchanges Lies Beyond Trading
Speaking at Point Zero Forum, Ben argues that tokenization solves access —…
June 25, 2026
SI Group and Shengxiao Group Establish Joint Venture to Accelerate Biphenol Capacity Expansion in China